RD Medicine

How To Recognize And Approach Suspected Acute Leukemia

USMLE
RD Medicine - USMLE

RD Medicine - USMLE

NOVEMBER 16, 2026
How To Recognize And Approach Suspected Acute Leukemia

Acute leukemias are malignant disorders characterized by the proliferation of immature hematopoietic cells known as blasts. These cells can occupy the bone marrow, interfere with normal blood cell production, and sometimes infiltrate other tissues.

Clinical presentation varies considerably. Some patients present only with fatigue and blood count abnormalities. Others present with severe infection, bleeding, hyperleukocytosis, or metabolic complications.

Recognizing the initial pattern is essential because some complications must be treated before the leukemia subtype has been completely defined.

Begin With The Consequences Of Bone Marrow Failure

Many symptoms result from the replacement of normal hematopoiesis by leukemic cells.

Anemia

Reduced red blood cell production may cause:

  • Fatigue.
  • Weakness.
  • Pallor.
  • Dyspnea.
  • Dizziness.
  • Tachycardia.
  • Exercise intolerance.

These symptoms are common but nonspecific. The clinical context and accompanying hematologic abnormalities help determine their significance.

Thrombocytopenia

A reduced platelet count may cause:

  • Petechiae.
  • Bruising.
  • Gingival bleeding.
  • Epistaxis.
  • Increased menstrual bleeding.
  • Persistent bleeding after procedures.
  • Severe hemorrhage in advanced cases.

Ask about medications that may further increase bleeding risk, including anticoagulants, antiplatelet agents, and nonsteroidal anti-inflammatory drugs.

Neutropenia Or White Blood Cell Dysfunction

Even when the total white blood cell count is elevated, the circulating cells may be immature and unable to function normally.

The patient may present with:

  • Fever.
  • Recurrent infections.
  • Oral ulcers.
  • Severe or unusual infections.
  • Sepsis.

Fever in a patient with neutropenia should be considered a clinical emergency.

Look For Signs Of Infiltration And A High Disease Burden

The proliferation of malignant cells may also cause:

  • Lymphadenopathy.
  • Hepatomegaly.
  • Splenomegaly.
  • Bone pain.
  • Abdominal discomfort.
  • Gingival hypertrophy.
  • Skin lesions.
  • Neurologic symptoms.
  • Weight loss.
  • Night sweats.

No single finding confirms leukemia. However, the combination of constitutional symptoms, cytopenias, and abnormal circulating cells should increase clinical suspicion.

Interpret The CBC As A Pattern

There is no single hematologic presentation of acute leukemia.

A patient may have:

  • Leukocytosis.
  • Leukopenia.
  • A white blood cell count within the reference range.
  • Anemia.
  • Thrombocytopenia.
  • Bicytopenia.
  • Pancytopenia.
  • Circulating blasts.

An elevated white blood cell count is not required. Similarly, the absence of recognized peripheral blood blasts does not exclude the diagnosis.

Always evaluate:

  1. Total white blood cell count.
  2. White blood cell differential.
  3. Hemoglobin.
  4. Platelet count.
  5. Trends over time.
  6. Peripheral smear findings.

The speed of change is also important. A CBC that changes significantly over days or weeks deserves particular attention.

Use The Peripheral Smear As A Clue

The peripheral smear may reveal blasts and other important morphologic abnormalities.

Certain findings may suggest a particular lineage or subtype. Auer rods, for example, support a myeloid origin. Abnormal promyelocytes accompanied by thrombocytopenia and coagulopathy raise concern for acute promyelocytic leukemia.

However, morphology alone is generally insufficient to classify the disease completely.

The smear should guide the level of urgency and the next tests, not replace the definitive investigation.

Order A Focused Initial Laboratory Evaluation

The initial evaluation commonly includes:

  • Complete blood count with differential.
  • Peripheral blood smear.
  • Metabolic panel.
  • Creatinine.
  • Potassium.
  • Phosphorus.
  • Calcium.
  • Uric acid.
  • Lactate dehydrogenase.
  • Liver function tests.
  • Coagulation studies.
  • Fibrinogen.
  • Blood type and antibody screen.
  • Cultures when infection is suspected.

These studies do more than investigate the diagnosis. They also identify complications requiring immediate treatment.

Confirm The Diagnosis And Define The Disease

The modern classification of acute leukemia integrates several types of information.

Bone Marrow Evaluation

Bone marrow aspiration and biopsy allow assessment of:

  • Blast percentage.
  • Cellularity.
  • Morphology.
  • Replacement of normal hematopoiesis.
  • Fibrosis and other abnormalities.

In selected circumstances, some studies may begin with peripheral blood, particularly when many circulating blasts are present. Bone marrow evaluation, however, remains central in many cases.

Immunophenotyping

Flow cytometry identifies the markers expressed by abnormal cells. It helps determine whether the disease has a myeloid, B-cell, T-cell, or ambiguous lineage.

It can also help distinguish acute leukemia from other hematologic disorders.

Cytogenetic And Molecular Testing

Chromosomal and molecular abnormalities may:

  • Define diagnostic entities.
  • Influence prognosis.
  • Guide treatment selection.
  • Identify potential targeted therapies.
  • Support measurable residual disease monitoring.

The diagnostic process should therefore not end with the general term “acute leukemia.” The disease should be classified as specifically as possible.

Recognize The Major Emergencies

Leukostasis

Hyperleukocytosis may compromise the microcirculation, particularly in the central nervous system and lungs.

Concerning findings include:

  • Dyspnea.
  • Hypoxemia.
  • Headache.
  • Confusion.
  • Visual changes.
  • Focal neurologic deficits.

The white blood cell count must be interpreted together with the leukemia type and the patient’s symptoms. Leukostasis is an emergency requiring immediate hematology evaluation.

Tumor Lysis Syndrome

Rapid destruction of malignant cells may release large amounts of intracellular material.

Findings may include:

  • Hyperuricemia.
  • Hyperphosphatemia.
  • Hyperkalemia.
  • Hypocalcemia.
  • Acute kidney injury.
  • Arrhythmias.
  • Seizures.

The syndrome may occur spontaneously or after treatment begins. Prevention and monitoring should reflect the tumor burden, diagnosis, kidney function, and planned therapy.

Febrile Neutropenia

Fever associated with neutropenia may represent a severe infection even when no localizing findings are present.

The assessment should consider:

  • Hemodynamic stability.
  • Absolute neutrophil count.
  • Localizing symptoms.
  • Cultures.
  • Possible infectious sources.
  • Recent treatment.

Treatment should not be delayed in high-risk or clinically unstable patients.

Bleeding And Coagulopathy

Thrombocytopenia, platelet dysfunction, and coagulation abnormalities may cause severe bleeding.

The combination of abnormal promyelocytes, low fibrinogen, and abnormal coagulation studies should immediately raise concern for acute promyelocytic leukemia.

Treat Suspected Acute Promyelocytic Leukemia As An Emergency

Acute promyelocytic leukemia is a subtype of acute myeloid leukemia associated with the PML::RARA fusion.

It is highly treatable, but early hemorrhage remains a major risk.

When APL is suspected:

  1. Request immediate hematology evaluation.
  2. Assess coagulation studies and fibrinogen.
  3. Begin transfusion support according to the clinical assessment and institutional protocol.
  4. Request urgent molecular confirmation.
  5. Avoid unnecessary invasive procedures.
  6. Consider the immediate initiation of ATRA according to specialist guidance and local protocols.

European LeukemiaNet recommendations state that suspected APL should be managed as a medical emergency and that ATRA should begin immediately without waiting for molecular confirmation. If APL is not confirmed, ATRA can be discontinued.

Organize Communication With The Team

A focused presentation may begin as follows:

“A 42-year-old patient presents with fatigue, gingival bleeding, and bruising and has anemia, thrombocytopenia, leukocytosis with immature cells, and coagulopathy, raising concern for acute leukemia and possible APL.”

Then report:

  • Clinical stability.
  • Bleeding or infection.
  • Neurologic or respiratory findings.
  • Blood counts.
  • Peripheral smear findings.
  • Creatinine and electrolytes.
  • Uric acid and LDH.
  • Coagulation results and fibrinogen.
  • Measures already initiated.
  • The immediate clinical question.

Avoid presenting every test indiscriminately. Prioritize information that defines severity, supports the assessment, and changes management.

Conclusion

Suspected acute leukemia begins with pattern recognition, not a single laboratory result.

Cytopenias, blasts, infections, bleeding, constitutional symptoms, and rapid changes in the CBC should be interpreted together.

The diagnostic evaluation incorporates morphology, bone marrow examination, immunophenotyping, cytogenetics, and molecular testing. However, emergencies such as leukostasis, tumor lysis syndrome, febrile neutropenia, and coagulopathy must be recognized and treated before the complete investigation is finished.

The initial goal is to answer three questions:

  1. Is acute leukemia present?
  2. Is there an immediate emergency?
  3. Which tests are required to confirm and classify the disease?

References

  1. Sanz MA, et al. Management of Acute Promyelocytic Leukemia: Updated Recommendations From an Expert Panel of the European LeukemiaNet. Blood. 2019.
  2. National Cancer Institute. Acute Myeloid Leukemia Treatment — Health Professional Version.
  3. National Cancer Institute. Adult Acute Lymphoblastic Leukemia Treatment — Health Professional Version.
  4. Brazilian Association of Hematology, Hemotherapy and Cellular Therapy. Brazilian Consensus Guidelines for the Diagnosis and Management of Acute Promyelocytic Leukemia. 2024.
  5. WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours. 5th ed.

Learn more about our school

I want to know more